Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 31, 2019 - Issue 10
547
Views
14
CrossRef citations to date
0
Altmetric
Articles

A missing perspective: injectable pre-exposure prophylaxis for people who inject drugs

ORCID Icon, ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Pages 1214-1220 | Received 05 Jun 2018, Accepted 07 Feb 2019, Published online: 01 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kristin E. Schneider, Rebecca Hamilton White, Allison O’Rourke, Michael E. Kilkenny, Michelle Perdue, Susan G. Sherman, Suzanne M. Grieb & Sean T. Allen. (2021) Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia. AIDS Care 33:6, pages 721-728.
Read now

Articles from other publishers (13)

Leanne Zhang, Joseph G. Rosen, Lyra Cooper, Praise F. Olatunde, Danielle Pelaez, Susan G. Sherman, Ju Nyeong Park & Jennifer L. Glick. (2023) Interrogating perceived relevance and feasibility of HIV pre-exposure prophylaxis: A novel model of PrEP acceptability among cisgender women who inject drugs. SSM - Qualitative Research in Health 4, pages 100337.
Crossref
Lara Lorenzetti, Nhi Dinh, Ariane van der Straten, Virginia Fonner, Kathleen Ridgeway, Michelle Rodolph, Robin Schaefer, Heather‐Marie A. Schmidt & Rachel Baggaley. (2023) Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition. Journal of the International AIDS Society 26:S2.
Crossref
Angela R. Bazzi, Michelle Bordeu, Katrina Baumgartner, Darien M. Sproesser, Christopher M. Bositis, Douglas S. Krakower, Matthew J. Mimiaga & Katie B. Biello. (2023) Study protocol for an efficacy trial of the “PrEP for Health” intervention to increase HIV PrEP use among people who inject drugs. BMC Public Health 23:1.
Crossref
Kerry L. Miley, Nguyen K. Tran, Latesha Elopre, Allison Groves, Jamila K. Stockman, Angela R. Bazzi, Adam Carrico, Silvana Mazzella & Alexis M. Roth. (2023) A Note on Pre-exposure prophylaxis (PrEP) preferences among women who inject drugs. Sexually Transmitted Diseases Publish Ahead of Print.
Crossref
Masunga K. Iseselo, Edith A. M. Tarimo, Eric Sandstrom & Asli Kulane. (2022) Awareness and willingness to use HIV oral pre-exposure prophylaxis among people who inject drugs in Dar es Salaam, Tanzania: A cross-sectional survey. PLOS Global Public Health 2:11, pages e0000776.
Crossref
Angela R. Bazzi, Chad J. ValasekSamantha A. StreuliCarlos F. VeraAlicia Harvey-VeraMorgan M. PhilbinKatie B. BielloAlexis M. RothSteffanie A. StrathdeeHeather A. Pines. (2022) Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California. AIDS Patient Care and STDs 36:7, pages 254-262.
Crossref
Morgan M. Philbin, Sadie Bergen, Carrigan Parish, Deanna Kerrigan, Elizabeth N. Kinnard, Sarah Reed, Mardge H. Cohen, Oluwakemi Sosanya, Anandi N. Sheth, Adaora A. Adimora, Jennifer Cocohoba, Lakshmi Goparaju, Elizabeth T. Golub, Michael Vaughn, José I. GutierrezJr.Jr., Margaret A. Fischl, Maria Alcaide & Lisa R. Metsch. (2021) Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most. AIDS and Behavior 26:4, pages 1260-1269.
Crossref
Sabrina A. Assoumou, Samantha M. Paniagua, Priscilla Gonzalez, Jianing Wang, Curt G. Beckwith, Laura F. White, Jessica L. Taylor, Kristen Coogan, Jeffrey H. Samet & Benjamin P. Linas. (2021) HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges. AIDS and Behavior 25:8, pages 2591-2598.
Crossref
Marisa Felsher, Eliza Ziegler, K. Rivet Amico, Adam Carrico, Jennie Coleman & Alexis M. Roth. (2021) “PrEP just isn't my priority”: Adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA. Social Science & Medicine 275, pages 113809.
Crossref
Dagmar Hedrich & Richard Lionel Hartnoll. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment 757 775 .
Roman Shrestha, Elizabeth E. DiDomizio, Rayne S. Kim, Frederick L. Altice, Jeffrey A. Wickersham & Michael M. Copenhaver. (2020) Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. Journal of Substance Abuse Treatment 117, pages 108058.
Crossref
Robert C Bollinger, Chloe L Thio, Mark S Sulkowski, Jane McKenzie-White, David L Thomas & Charles Flexner. (2020) Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV. The Lancet HIV 7:6, pages e443-e448.
Crossref
Benedikt PleuhsKatherine G. QuinnJennifer L. WalshAndrew E. PetrollSteven A. John. (2020) Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review. AIDS Patient Care and STDs 34:3, pages 111-123.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.